KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Equity: 2017-2024

Historic Return on Equity for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Dec 2024 value amounting to 1.65%.

  • Amneal Pharmaceuticals' Return on Equity fell 246.00% to -0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.52%, marking a year-over-year decrease of 246.00%. This contributed to the annual value of 1.65% for FY2024, which is 213.00% up from last year.
  • Amneal Pharmaceuticals' Return on Equity amounted to 1.65% in FY2024, which was up 445.42% from -0.48% recorded in FY2023.
  • Amneal Pharmaceuticals' Return on Equity's 5-year high stood at 1.65% during FY2024, with a 5-year trough of -0.93% in FY2022.
  • Over the past 3 years, Amneal Pharmaceuticals' median Return on Equity value was -0.48% (recorded in 2023), while the average stood at 0.08%.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Return on Equity slumped by 98bps in 2022, and later surged by 213bps in 2024.
  • Yearly analysis of 5 years shows Amneal Pharmaceuticals' Return on Equity stood at 0.20% in 2020, then decreased by 14bps to 0.06% in 2021, then slumped by 98bps to -0.93% in 2022, then surged by 45bps to -0.48% in 2023, then skyrocketed by 213bps to 1.65% in 2024.